On (b)(6) 2020, the physician sized the mitral valve and a 33mm biocor stented porcine valve was selected for implant in the patient.Upon closure, mitral regurgitation was observed on echo.Initially, it was thought that a wrong size was used now the thought is that it was a faulty valve.The physician resized the mitral valve and selected a 31mm biocor stented porcine valve.The 31mm valve was implanted with better outcomes.
|
An event of regurgitation was reported.No anomalies were found with the valve cusps, and functional testing at the time of manufacturing and upon return to abbott indicated the valve functioned normally.This test ensures proper cuspal coaptation and hemodynamic performance.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.In the absence of any evidence of valve anomaly that may impact valvular function, the reported event is consistent with a non-structural valve dysfunction.Non-structural valve dysfunction (nsvd) is a known potential complication of valve replacement surgery as outlined in the instructions for use.Nsvd is commonly attributed to implant-related technical factors such as inappropriate sizing or positioning, entrapment by suture, stent deformation, or mishandling of the leaflet tissue.In this case, it is possible that the valve was inappropriately sized as a smaller (31mm) valve was successfully implanted.Temporary distortion of the stent due to external forces following closure where the stent is not permanently deformed may also potentially explain the observed intraoperative valvular dysfunction.The exact cause of the observed intra-operative regurgitation cannot be conclusively determined.
|